✦ LIBER ✦

Activity of phosphodiesterase type 5 inhibitors in patients with lower urinary tract symptoms due to benign prostatic hyperplasia

✍ Scribed by Chen Zhao; Suhn Hee Kim; Sung Won Lee; Ju-Hong Jeon; Kyung Ku Kang; Sung Beom Choi; Jong Kwan Park

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phosphodiesterase 5 inhibitors for lower

✍ Humberto K. Laydner; Paulo Oliveira; Carlos Roberto A. Oliveira; Tafadzwa P. Mak 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 223 KB

Managing patients with lower urinary tra

✍ Mary McNaughton-Collins; Michael J. Barry 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 412 KB

Chronic kidney disease among men with lo

✍ Sung Kyu Hong; Seung Tae Lee; Sung Jin Jeong; Seok-Soo Byun; Young Kwon Hong; Do 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 204 KB

Re: Phosphodiesterase-5 Inhibitors for L

✍ Kaplan, Steven A. 📂 Article 📅 2011 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 64 KB

Combination of phosphodiesterase-5 inhib

✍ CULLEY C. CARSON 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB

Pre-clinical evidence for the use of pho

✍ Hanna Tinel; Beatrix Stelte-Ludwig; Joachim Hütter; Peter Sandner 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 184 KB